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Paraquat (PQ) is a dopaminergic neurotoxin and a well-known pneumotoxicant that exerts its toxic effect via oxidative stress-
mediated cellular injuries. This study investigated the protective effects of Tualang honey against PQ-induced toxicity in the
midbrain and lungs of rats. The rats were orally treated with distilled water (2mL/kg/day), Tualang honey (1.0 g/kg/day), or
ubiquinol (0.2 g/kg/day) throughout the experimental period. Two weeks after the respective treatments, the rats were injected
intraperitoneally with saline (1mL/kg/week) or PQ (10mg/kg/week) once per week for four consecutive weeks. After four weekly
exposures to PQ, the glutathione peroxidase activity and the number of tyrosine-hydroxylase immunopositive neurons in the
midbrain were significantly decreased in animals from group PQ (𝑝 < 0.05). The lungs of animals from group PQ showed
significantly decreased activity of superoxide dismutase and glutathione-S-transferase. Treatment with Tualang honey ameliorated
the toxic effects observed in the midbrain and lungs.The beneficial effects of Tualang honey were comparable to those of ubiquinol,
which was used as a positive control. These findings suggest that treatment with Tualang honey may protect against PQ-induced
toxicity in the rat midbrain and lung.
1. Introduction
Paraquat (PQ), or 1,1󸀠-dimethyl-4,4󸀠-bipyridinium, is a
nonselective contact herbicide commonly used to control
broadleaf and grassy weeds. Currently, it is among the most
frequently used weed killers in approximately 100 countries.
Since its first introduction in the early 1960s, problems
resulting fromPQuse, for example, suicidal intent, accidental
poisoning, or occupational exposure, have frequently been
reported [1].
PQ is a strong electron acceptor and readily undergoes
a single-electron reduction to form the monocation radical
(PQ+∙). This radical is rapidly reoxidized by molecular oxy-
gen, regenerating the dicationic form (PQ2+) and generating
a superoxide radical (O2
∙). The process of PQ redox cycling
and the initiation of the cascade reaction by O2
∙− leads to the
formation of various reactive oxygen species (ROS) [2, 3],
which readily attack key cellular structures and molecules
(lipids, carbohydrates, proteins, and nucleotides), leading to
deleterious cellular effects underlying various diseases [4].
The effect of chronic exposure to PQ, particularly among
agricultural workers and PQ formulationworkers, has gained
considerable attention due to the wide use of PQ around the
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world. Unlike the major pneumotoxic effects of acute poi-
soning [2, 5], repeated low-dose exposure to PQ is believed
to be neurotoxic and may be involved in the pathogenesis
of Parkinson’s disease [6, 7]. There is growing evidence from
epidemiological studies indicating the possible involvement
of environmental toxins, such as pesticides, as an important
etiological factor for Parkinson’s disease. Studies conducted
by Liou et al. [8] andHertzman et al. [9] showed that exposure
to PQ was associated with increased incidence of Parkinson’s
disease.
PQ first received research interest as a potential neuro-
toxin due to its structural similarity to 1-methyl-4-phenylpyr-
idinium (MPP+), a known dopaminergic neurotoxin that
induces Parkinson-like symptoms in both humans and exper-
imental animals [10, 11]. The brain naturally contains rela-
tively low levels of antioxidants and high amounts of polyun-
saturated fatty acids, making it more susceptible to oxidative
injuries from redox imbalance [12]. Of the neuronal cell
types in the brain, dopaminergic neurons in the nigrostriatal
system are selectively vulnerable to oxidative injury because
dopamine metabolism itself generates high levels of ROS
[7, 13]. A recent report by Pacelli et al. [14] demonstrated that
dopaminergic neurons of the substantia nigra pars compacta
(SNpc) have a more complex axonal arborization and denser
populations of axonal mitochondria and therefore have
higher basal energy demands, consequently placing these
neurons at higher risk in Parkinson’s disease. PQ-induced
oxidative stress has been demonstrated in the substantia
nigra (SN) in Parkinson’s disease brain [15]. In experimental
models, rats or mice exposed to PQ demonstrate a selective
degeneration of nigrostriatal dopaminergic neurons, a neu-
ropathological hallmark of Parkinson’s disease [13, 16].
Because the suggested primary mechanism for PQ toxic-
ity, either acute or chronic, involves the production of ROS,
it is plausible that an antidote against PQ poisoning should
be a substance that can confer strong antioxidant properties.
Honey is known to be rich in both enzymatic and nonen-
zymatic antioxidants, including both aqueous and lipophilic
antioxidants, and the interactions among these antioxidants
suggest that honey may be an ideal natural antioxidant that
can act at multiple subcellular locations in the case of PQ
poisoning [17, 18].
Tualang honey is a wild honey harvested from Tualang
trees found in the Malaysian rain forest. Various studies
have been conducted to evaluate its possible medicinal uses,
including anticancer properties of Tualang honey in cell
culture and animal models [19, 20], protective effects against
damage induced by cigarette smoke on the rat male repro-
ductive system [21], an animal model of menopause [22], an
animal model of diabetes [23, 24], and its wound healing and
antimicrobial properties [25–27].
The neuroprotective effects of Tualang honey have pre-
viously been reported in chronic cerebral hypoperfusion-
induced neurodegeneration in the rat hippocampus [28]. In
addition, in stressed ovariectomized rats, supplementation of
Tualang honey improved the morphology of the hippocam-
pus and medial prefrontal cortex, the performance of mem-
ory tasks, and the cholinergic system [29, 30].However, to our
knowledge, there is no study reporting on the potential bene-
ficial effects of Tualang honey against PQ-induced neurotox-
icity. In addition, the effects of Tualang honey against PQ-
induced pneumotoxicity have also been evaluated because
PQ is a well-known pneumotoxicant.Therefore, the objective
of this study is to investigate the possible neuroprotective and
pneumoprotective effects of Tualang honey in rats exposed to
four weekly injections of PQ.
2. Materials and Methods
2.1. Ethics Statement. The ethical approval for this study
was obtained from the Animal Ethics Committee, Universiti
Sains Malaysia (USM) [Approval No.: USM/Animal Ethics
Approval/2012/(75)(398)] in accordance with the Institu-
tional Guidelines for the Care and Use of Animals for
Scientific Purposes. Eight-week-old male Sprague-Dawley
rats were purchased from the Animal Research and Service
Centre, Health Campus, USM, Kubang Kerian, Kelantan,
Malaysia. All animals were individually housed in a well-
ventilated animal room maintained with a 12-hour/12-hour
light/dark cycle and a temperature of 25 ± 2∘C. The animals
were allowed access to food pellets and water ad libitum
unless otherwise stated. All rats were acclimatized to the
animal room conditions for at least one week before the
experiments started.
2.2. Tualang Honey. The Tualang honey (AgroMas) used in
this studywas supplied by the Federal AgriculturalMarketing
Authority (FAMA), Kedah, Malaysia. The honey samples
were filtered, concentrated to 20% (w/v) water content at
40∘C, and sterilized by gamma irradiation at 25 kGy [Steril-
gamma (M) Sdn. Bhd., Selangor, Malaysia]. The same batch
of honey was used throughout the analysis.
2.3. Experimental Design. A total of 75 rats were randomly
divided into five groups of 15 animals each: control (N), honey
(TH), paraquat (PQ), paraquat + honey (PQ + TH), and
paraquat + ubiquinol (PQ + QH). Throughout the exper-
iment, groups N and PQ were treated with distilled water
(2.0mL/kg/day, p.o.), groups TH and PQ + TH were treated
withTualang honey (AgroMas, FAMA, 1.0 g/kg/day, p.o.), and
group PQ + QH was treated with ubiquinol (0.2 g/kg/day,
p.o.) once per day (Figure 1). The dose of Tualang honey
was chosen based on previous studies that showed protective
effects against other oxidative stress-related diseases [21, 31–
33], while the selected ubiquinol dose was based on the
studies by Cleren et al. [34] and Matthews et al. [35]. Two
weeks after the respective treatments, rats were administered
intraperitoneal injections of vehicle (0.9% NaCl, 1.0mL/kg;
Group N and TH) or PQ (Sigma-Aldrich, 10mg/kg; Group
PQ, PQ + TH and PQ + QH) once per week for four
consecutive weeks. One week after the final injection of
saline or PQ, the rats were fasted overnight and sacrificed for
biochemical (𝑛 = 8 per group) or immunohistochemical (𝑛 =
7 per group) analyses. Bodyweight changes, renal profile, and
liver profile were included as general health assessments.
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Intraperitoneal injection of 
saline or paraquat (PQ)
∗Experimental groups:
Male Sprague-Dawley rats (n = 15 per group)
Group N: dH2O (2mL/kg/day × 7 weeks, p.o.) + saline (1mL/kg/week × 4 weeks, i.p.)
Group TH: honey (1g/kg/day × 7 weeks, p.o.) + saline (1mL/kg/week × 4 weeks, i.p.)
Group PQ: dH2O (2mL/kg/day × 7 weeks, p.o.) + PQ (10mg/kg/week × 4 weeks, i.p.)
Group PQ + TH: honey (1g/kg/day × 7 weeks, p.o. ) + PQ (10mg/kg/week × 4 weeks, i.p.)
Group PQ + QH: QH (0.2 g/kg/day × 7 weeks, p.o. ) + PQ (10mg/kg/week × 4 weeks, i.p.)
Sacrifice and tissue collection 
(brain and lung)
Biochemical
analyses
(n = 8)
Immunohistochemical
and histological analyses
(n = 7)
Week 4Week 3Week 2Week 1Week 0Week −1Week −2
Daily oral administration of double distilled water (ddH2O), Tualang honey (TH), or ubiquinol (QH)
Figure 1: Experimental procedure. A total of 75 rats were randomly divided into five groups of 15 animals each and were orally treated with
distilled water (dH2O, 2mL/kg/day), Tualang honey (TH, 1 g/kg/day), or ubiquinol (QH, 0.2 g/kg/day) throughout the experimental period.
Two weeks after these treatments, the rats were injected with saline (1mL/kg/week) or PQ (PQ, 10mg/kg/week) once a week (open circles)
for four consecutive weeks. A week after the last injection, the rats were sacrificed for biochemical (𝑛 = 8) or immunohistochemical (IHC,
𝑛 = 7) analyses.
2.4. Biochemical Analysis
2.4.1. Sample Collection. The rats (𝑛 = 8 per group)
were fasted overnight and were deeply anaesthetized with
intramuscular injection of ketamine (90mg/kg) plus xylazine
(5mg/kg). Blood samples (5mL) were collected via the portal
vein into plain tubes and were allowed to clot at 4∘C before
being centrifuged at 3000×g for 15min. The serum yielded
was aliquoted and temporarily stored at 4∘C before being
outsourced to a private laboratory (BP Healthcare, Malaysia)
for tests of renal and liver function. Immediately after blood
collection, brain and lung samples were rapidly dissected out,
rinsed with ice-cold phosphate-buffered saline (PBS) (1x, pH
7.4) to remove any residual blood, and stored at −80∘C for
subsequent biochemical analyses.
2.4.2. Preparation of Tissue Homogenate. The midbrain
region was identified and dissected according to the method
described by Heffner et al. [36]. The harvested midbrain
region and the right lung were homogenized in ice-cold
potassium phosphate buffer (0.1M, pH 7.4) to produce a 10%
(w/v) homogenate using amotor-driven Teflon-glass homog-
enizer. The samples were then centrifuged at 10,000×g for
10min at 4∘C. Aliquots of the resulting supernatant were used
for the measurement of total protein; the activities of super-
oxide dismutase (SOD), catalase (CAT), glutathione peroxi-
dase (GPx), glutathione reductase (GR), and glutathione-S-
transferase (GST); and the total levels of glutathione (GSH)
and malondialdehyde (MDA), using commercially available
assay kits. The assay kits for quantifying total protein, SOD,
GPx, GR, GST, total GSH, and MDA were purchased from
Cayman Chemical Company (USA). The assay kit for CAT
was purchased from BioAssay Systems (USA). Additionally,
the midbrain tyrosine hydroxylase (TyrH) concentration was
measured using an ELISA kit from Cusabio Biotech, China.
2.5. Immunohistochemical Analysis of Tyrosine Hydroxylase
2.5.1. Sample Collection. The rats (𝑛 = 7 per group) were
fasted overnight, deeply anesthetized with ketamine/xylazine
mixture, and perfused transcardially with prechilled PBS
buffer, followed by 4% paraformaldehyde prepared in 0.1M
phosphate buffer (pH7.4) [37].Thebrainswere removed from
the cranium and postfixed in the same fixative for another
48–72 hours at 4∘C before being processed for tyrosine
hydroxylase (TyrH) immunohistochemistry.
2.5.2. TyrosineHydroxylase Immunohistochemistry. Midbrain
dopaminergic neurons were stained with TyrH antibody
for evaluation of midbrain damage based on the number
of TyrH-positive neurons in the SNpc region. After the
fixation period, the striatum and midbrain were identified
and dissected according to the rat brain atlas [38]. The
coronal sections containing the striatum (anterior-posterior
[A-P] = +1.5 to −1.0mm from bregma) and substantia nigra
(AP = −4.8 to −6.5mm from bregma) were collected for
immunohistochemical (IHC) staining of TyrH.The sectioned
tissues were processed using an automated tissue processor
before being embedded in paraffin blocks. Tissue sections
(3 𝜇m thick) were prepared using a rotary microtome and
were then mounted on poly-L-lysine-coated slides. Prior to
IHC staining of TyrH, the slides were heated overnight in an
oven at 60∘C to increase tissue adherence. A tissue section
from the striatum (as a positive control) and a tissue section
from the liver (as a negative control) were included in each
batch of staining.
Briefly, the tissue sections were deparaffinized with
xylene, rehydrated in decreasing concentrations of ethanol,
and washed with 1x Tris buffered saline (TBS) wash
buffer (pH 7.6; Dako, Denmark) and double-distilled water
(ddH2O). The rehydrated tissue sections were microwaved
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Table 1: Body weight changes (percentage relative to week 0, injection week) in all experimental groups.
Week Body weight changes relative to week 0 (%) 𝑝 value∗
N TH PQ PQ + TH PQ + QH
1 3.97 (5.20) 3.94 (2.56) 2.36 (5.51)a,e 2.36 (4.40)a,f 2.33 (1.71)b,g 0.003
2 7.79 (6.50) 7.45 (3.63) 5.51 (7.25)a,e 4.94 (6.93)b,g 3.79 (2.78)c,h <0.001
3 11.02 (4.86) 10.32 (7.48) 6.96 (7.54)c,e 7.19 (12.58)b,e 4.21 (4.97)c,g <0.001
4 13.90 (4.00) 13.43 (8.18) 8.12 (10.95)c,g 8.50 (13.38)a,e 4.75 (7.02)d,h <0.001
Data are expressed as the median (IQR), 𝑛 = 15 per group.
∗𝑝 values were calculated using the Kruskal-Wallis test. A 𝑝 value < 0.05 indicates a statistically significant difference between the investigated groups.
a𝑝 < 0.05, b𝑝 < 0.01, c𝑝 < 0.005, and d𝑝 < 0.001 compared to group N; e𝑝 < 0.05, f𝑝 < 0.01, g𝑝 < 0.005, and h𝑝 < 0.001 compared to group TH.
with citrate buffer (pH 6; Dako, Denmark) for anti-
gen retrieval, blocked with peroxidase-blocking solution
(REAL, Dako, Denmark), and incubated overnight with
TyrH antibody raised in rabbit (AB152, Millipore, 1 : 10,000
dilution) at 4∘C. The tissues were then rinsed with 1x TBS
wash buffer, incubated with horseradish peroxidase- (HRP-)
conjugated secondary antibody, and exposed to diaminoben-
zidine (DAB) as a substrate (REAL EnVision Detection
Systems, K5007, Dako, Denmark). The HRP reacts with
the DAB substrate to produce a brown product. The slides
were then counter-stained with hematoxylin (Sigma-Aldrich,
USA), subsequently dehydrated in increasing concentrations
of ethanol, cleared with xylene, and sealed with coverslips.
The slides were examined under a lightmicroscope (Olympus
BX41, Japan). The number of TyrH-positive neurons in the
SNpc region was determined in three sections from each rat.
The SNpc was delineated with reference to the rat brain atlas
[38]. The TyrH-positive neurons were identified by dense
cytoplasmic immunolabeling.
2.6. Statistical Analysis. Statistical analysis was performed
using IBM SPSS software version 22.0 (Armonk, NY, USA).
Data that were normally distributed are presented as the
mean (standard deviation).The differences among themeans
of the groups were analyzed using one-way analysis of
variance (ANOVA). If the ANOVA showed a significant
difference, Tukey’s post hoc test was performed to determine
the pairwise differences of the means. Data that were not
normally distributed are expressed as the median (interquar-
tile range [IQR]). The differences among the medians of
the groups were analyzed using the Kruskal-Wallis test,
and if significant, the Mann-Whitney 𝑈-test was performed
for pairwise comparisons of the medians. Differences were
considered statistically significant when 𝑝 < 0.05.
3. Results
3.1. Changes in Body Weight. Generally, the body weight of
rats from all experimental groups progressively increased
(Figure 2). However, the body weight gain in all PQ-treated
groups (PQ, PQ + TH, and PQ +QH) was significantly lower
than in the vehicle control groups (N and TH) (𝑝 = 0.003 at
week 1 and 𝑝 < 0.001 at weeks 2, 3, and 4 when compared to
week 0; Table 1). Treatment with Tualang honey or ubiquinol
did not significantly affect the body weight of PQ-intoxicated
rats.
PQ injection weeksPre-PQ injectionweeks
Post-PQ
injection
320
340
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380
400
420
440
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 w
ei
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N
TH
PQ
PQ + TH
PQ + QH
Figure 2:Mean bodyweight (g) of rats throughout the experimental
period (𝑛 = 15 per group). Overall, the body weight of rats from
all experimental groups showed an increasing trend throughout the
experimental period.
3.2. Serum Biochemical Parameters
3.2.1. Renal Profile. No significant differences in the serum
levels of sodium, potassium, chloride, and uric acid were
observed among the experimental groups. The rats that
received honey (groups TH and PQ + TH) and ubiquinol
(groups PQ+QH) showed a significant decrease in the serum
urea level (𝑝 < 0.05 for group TH, 𝑝 < 0.005 for groups PQ +
TH and PQ + QH) compared to that in group N. The serum
urea level in group PQ + THwas also significantly lower than
that in groupPQ (𝑝 < 0.05). In addition, the serum creatinine
level in group PQ+THwas significantly lower than in groups
N (𝑝 < 0.01) and TH (𝑝 < 0.05) (Table 2).
3.2.2. Liver Profile. No significant differences were observed
for serum levels of total protein or for aspartate transaminase
(AST) or alkaline phosphatase (ALP) activity in any of the
experimental groups. However, serum alanine transaminase
(ALT) activity was significantly higher in group PQ than in
group TH (𝑝 < 0.05). Treatment with honey (group PQ +
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Table 2: Serum biochemical parameters in all the experimental groups.
Parameters Groups 𝑝 value∗
N TH PQ PQ + TH PQ + QH
¶Sodium (mmol/dL) 139.00 (2.00) 138.00 (4.00) 140.00 (6.00) 140.00 (5.00) 140.00 (2.00) 0.129
#Potassium (mmol/dL) 5.11 (0.23) 5.08 (0.37) 5.10 (0.40) 4.80 (0.38) 4.65 (0.50) 0.069
#Chloride (mmol/dL) 101.50 (2.67) 101.00 (2.51) 102.00 (1.69) 101.38 (3.38) 103.00 (2.51) 0.595
¶Urea (mg/dL) 38.00 (6.00) 29.50 (8.00)a 34.50 (6.00) 29.50 (4.00)c,e 31.50 (8.00)c 0.005
¶Creatinine (mg/dL) 0.50 (0.00) 0.50 (0.00) 0.50 (0.10) 0.40 (0.10)b,d 0.50 (0.10) 0.039
¶Uric acid (mg/dL) 1.20 (0.40) 1.15 (0.70) 1.15 (0.40) 1.00 (0.30) 1.00 (0.30) 0.384
#Total protein (g/dL) 5.91 (0.32) 5.83 (0.30) 5.75 (0.42) 5.59 (0.39) 5.56 (0.28) 0.217
¶AST (U/L) 77.00 (42.00) 72.00 (17.00) 85.50 (40.00) 72.00 (17.00) 66.50 (21.00) 0.236
¶ALT (U/L) 34.00 (15.00) 33.00 (14.00)e 40.00 (6.00) 29.50 (5.00)f 31.50 (7.00) 0.049
#ALP (U/L) 127.00 (34.43) 112.13 (22.66) 118.13 (21.46) 113.38 (22.45) 106.13 (27.38) 0.590
Data are presented as the #mean (SD) or the ¶median (IQR), 𝑛 = 8 per group.
∗𝑝 values were calculated using one-way ANOVA or the Kruskal-Wallis test. A 𝑝 value < 0.05 indicates a statistically significant difference between the
investigated groups.
a𝑝 < 0.05, b𝑝 < 0.01, and c𝑝 < 0.005 compared to group N; d𝑝 < 0.05 compared to group TH; e𝑝 < 0.05, f𝑝 < 0.005 compared to group PQ.
Table 3: Comparison of oxidative stress parameters in the midbrain among all experimental groups.
Parameters Groups 𝑝 value∗
N TH PQ PQ + TH PQ + QH
#SOD (U/mg protein) 52.54 (5.57) 51.60 (8.07) 48.17 (5.31) 52.76 (6.43) 52.90 (8.35) 0.619
#CAT (U/mg protein) 23.85 (4.30) 27.09 (9.23) 20.64 (5.41) 26.45 (7.48) 21.86 (5.74) 0.248
#GPx (U/mg protein) 43.06 (3.52) 40.48 (3.78) 37.50 (4.81)a 40.50 (2.77) 37.55 (3.88)∗ 0.031
¶GR (U/mg protein) 12.71 (2.85) 13.72 (3.62) 14.72 (1.80) 13.49 (3.91) 13.03 (4.24) 0.530
#GST (U/mg protein) 37.05 (4.42) 37.67 (3.91) 38.68 (3.05) 36.13 (4.03) 37.05 (2.92) 0.727
#Total GSH (𝜇M/mg protein) 362.05 (64.49) 375.10 (38.48) 340.45 (72.31) 381.39 (37.93) 377.68 (24.45) 0.495
#MDA level (𝜇M/mg protein) 0.70 (0.29) 0.69 (0.26) 1.09 (0.67) 0.65 (0.13) 0.58 (0.27) 0.074
Data are presented as the #mean (SD) or the ¶median (IQR), 𝑛 = 8 per group.
∗𝑝 values were calculated using one-way ANOVA or the Kruskal-Wallis test. A 𝑝 value < 0.05 indicates a statistically significant difference between the
investigated groups.
a𝑝 < 0.05 compared to group N.
TH) significantly reducedALT activity in PQ-intoxicated rats
(𝑝 < 0.005) (Table 2).
3.3. The Effects of PQ and Tualang Honey on the Rat Midbrain
3.3.1. Assessment of Oxidative Stress Parameters. The present
study showed that there were no significant differences in
the enzymatic activities of SOD, CAT, GR, and GST in the
midbrain region among all experimental groups. However,
the midbrain GPx activity was significantly lower in groups
PQ and PQ + QH (𝑝 < 0.05; Table 3). Measurement of
the total GSH level also showed no significant differences
among the investigated groups. The level of MDA, a marker
for lipid peroxidation, was higher in group PQ than in all
other experimental groups, although this difference did not
reach statistical significance (𝑝 = 0.074).
3.3.2. Assessment of Damage to Midbrain Dopaminergic
Neurons. Damage to midbrain dopaminergic neurons was
assessed via measurement of the midbrain TyrH concentra-
tion and immunohistochemical assessment of TyrH-positive
neurons in the SNpc. None of the experimental groups
showed a significant change in the mean TyrH level (Fig-
ure 3). Microscopic examination of TyrH-positive neurons
in the SNpc (Figure 4(a)) showed a decreased number of
TyrH-positive neurons in group PQ. Neuronal loss was also
observed in group PQ based on a decrease in TyrH-positive
fibers. The number of TyrH-positive neurons counted in the
threemidbrain sections containing the SNpcwas significantly
lower in group PQ than in group N (𝑝 = 0.007). However,
treatment with QH significantly increased the number of
TyrH-positive neurons (𝑝 = 0.039). The number of TyrH-
positive neurons also increased in group PQ + TH, although
this difference did not reach statistical significance (𝑝 =
0.059) (Figure 4(b)).
3.4. The Effects of PQ and Tualang Honey on Rat Lung
3.4.1. Assessment of Oxidative Stress Parameters. PQ-intoxi-
cated rats (group PQ) showed significantly lower total SOD
activity than the control (𝑝 < 0.005) and honey (𝑝 < 0.05)
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Table 4: Comparison of oxidative stress parameters in the lungs among all experimental groups.
Parameters Groups 𝑝 value∗
N TH PQ PQ + TH PQ + QH
¶SOD (U/mg protein) 20.75 (6.40) 18.53 (3.03)b 17.39 (2.76)a 19.25 (3.93)b 20.37 (9.53)b 0.019
#CAT (U/mg protein) 95.35 (12.05) 97.12 (8.86) 79.23 (17.46) 96.71 (19.61) 95.40 (13.83) 0.102
#GPx (U/mg protein) 227.95 (29.88) 220.38 (23.96) 205.88 (25.89) 209.59 (29.98) 227.60 (31.93) 0.409
#GR (U/mg protein) 19.04 (3.62) 19.09 (2.38) 17.73 (2.76) 19.63 (2.54) 18.31 (2.43) 0.689
#GST (U/mg protein) 22.65 (1.33) 20.74 (1.81) 16.73 (5.26)a 20.36 (1.90) 18.80 (3.41) 0.008
#Total GSH (𝜇M/mg protein) 135.78 (33.60) 112.03 (29.45) 90.43 (35.07) 120.52 (16.77) 143.77 (53.12)b 0.043
#MDA level (𝜇M/mg protein) 1.42 (0.14) 1.63 (0.32) 1.46 (0.14) 1.39 (0.33) 1.57 (0.27) 0.312
Data are presented as the #mean (SD) or the ¶median (IQR), 𝑛 = 8 per group.
∗𝑝 values were calculated using one-way ANOVA or the Kruskal-Wallis test. A 𝑝 value < 0.05 indicates a statistically significant difference between the
investigated groups.
a𝑝 < 0.005 compared to group N; b𝑝 < 0.05 compared to group PQ.
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Figure 3: Midbrain concentrations of TyrH for all experimental
groups. Data are presented as the mean ± SEM, 𝑛 = 8 per group.
No significant differences (𝑝 = 0.637) were observed among all the
experimental groups.
groups. The PQ-intoxicated rats that received honey (𝑝 <
0.05) or ubiquinol treatments (𝑝 < 0.05) showed significantly
greater SODactivity, at levels comparable to that of the vehicle
control group (𝑝 > 0.05). No significant differences were
observed in the mean GST activity among the investigated
groups, except for group PQ. GST activity was significantly
lower in PQ-treated rats than in group N (𝑝 < 0.005). In
addition, the total GSH level in the lungs was also lower in
group PQ than in groups N and TH, although this difference
is not statistically significant (𝑝 > 0.05). However, the total
GSH level in the lungs was significantly higher in group PQ +
QH than in group PQ (𝑝 < 0.05). No significant differences
among the experimental groups were observed for the other
parameters (Table 4).
4. Discussion
Our study is the first to show that Tualang honeymay provide
some protection to the rat midbrain and lung following
repeated exposure to PQ. In the present study, all groups of
rats treated with PQ (PQ, PQ + TH, and PQ + QH) showed
significantly reduced rates of body weight gain compared
to that in the vehicle control groups (N and TH). The
significantly smaller gains in body weight were observed as
early as one week following the first PQ administration. The
overall slower body weight gain may be attributable to the
lower food intake, particularly in the first two to three days
following PQ administration (data not shown). PQ-induced
conditioned taste aversion and weight loss have previously
been shown to be mediated by the area postrema of the
hypothalamus [39, 40]. Studies by Chanyachukul et al. [41]
suggest a PQ-induced significant reduction of noradrenaline
content in the hypothalamus that may contribute to the taste
aversion and weight loss in rats. However, no significant
differences in the total food intake among the experimental
groups were observed in this study.
Abnormal renal and liver functions have often been
observed in animal models of PQ poisoning [42, 43]. In the
present study, the serum biochemical parameters did not dif-
fer significantly between the control (N) and paraquat-treated
(PQ) group. However, Tualang honey treatment (group TH)
produced a significant reduction in serum urea content when
compared to that of group N, as well as in group PQ + TH
when compared to that of group PQ. The serum creatinine
level was also markedly lower in group PQ + TH than in
groups N and TH. In addition, the two groups receiving
honey (TH and PQ + TH) showed significantly lower ALT
activity than group PQ. Similarly, lower AST activity was
observed in groups TH and PQ + TH than in group PQ.
Similar to our findings, Al-Waili [44] previously reported that
a daily consumption of honey for two weeks increased blood
levels of antioxidants and could even decrease the levels of
the liver enzymes AST and ALT in normal individuals. Non-
significant decrease in the levels of blood urea nitrogen and
serum creatinine has also previously been reported among
normal subjects receiving honey [45], indicating that honey
may confer some protective effects on the affected organs
due to its high antioxidant content [46]. In animal models,
honey administration reduced blood urea nitrogen, serum
creatinine, AST, and ALT in healthy sheep and showed hep-
atoprotective effects against carbon tetrachloride-induced
liver injury [47]. A recent study by Tanvir et al. [48] showed
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Figure 4: TyrH immunohistochemical staining for evaluating damage to dopaminergic neurons. (a) Representative photomicrographs
showing TyrH-immunopositive neurons in coronal sections showing the midbrain. The higher magnification (×200) for the boxed region
shows the reduction in TyrH-positive neurons. (b) The numbers of TyrH-positive neurons in the SNpc regions were counted. Data are
presented as the mean ± SEM, 𝑛 = 7 per group. The number of TyrH-positive neurons was significantly lower in PQ-intoxicated rats than in
groupN (A𝑝 = 0.007). Compared with group PQ, the number of TyrH-positive neurons increased in group PQ+TH, although this difference
is not statistically significant (𝑝 = 0.059). Group PQ + QH showed a significant increase in the number of TyrH-positive neurons compared
to group PQ (B𝑝 = 0.039).
that honey supplementation can ameliorate chlorpyrifos-
induced renal and liver toxicities in rats, which was mainly
attributed to the antioxidant properties of the honey. The
hepatoprotective effects of Tualang honey were previously
observed in streptozotocin- (STZ-) induced diabetic rats [33].
However, because the present study did not include the serum
levels of antioxidants and oxidative stress markers, further
investigations are needed to understand the exactmechanism
of the protective function observed here.
Following four weekly systemic administrations of PQ to
rats, oxidative injuries to the midbrain were demonstrated
by significantly lower GPx activity than in the control group.
In addition, group PQ also showed lower activities of SOD
and CAT, a lower total GSH level, and a higher level of MDA
compared to the control group, although these differences
were not statistically significant. No significant differences
in the midbrain TyrH concentration were observed among
the experimental groups. However, immunohistochemical
assessment of the SNpc showed a significant reduction in the
number of TyrH-positive neurons in group PQ, indicating
damage to dopaminergic neurons. PretreatmentwithTualang
honey or ubiquinol two weeks prior to injection of PQ
ameliorated the toxic effects of PQ, suggesting that Tualang
honey or ubiquinol protects dopaminergic neurons against
oxidative stress-related damage, possibly via an antioxidant
defense mechanism.
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Asmentioned above, PQ readily undergoes cellular redox
cycling to induce the generation of free radicals. In addition,
an increased rate of dopamine oxidation was previously
reported in the SN of mice following repeated PQ injections
(i.p., twice weekly for three consecutive weeks) [49], which
could also serve as an additional source for ROS production.
Excessive generation of free radicals is one plausible explana-
tion for the decrease in SOD and GPx activities in group PQ.
The depletion of these antioxidants in group PQ may render
the midbrain region more vulnerable to oxidative damage
[50, 51]. Similarly, a study conducted by Mehdi and Qamar
[52] showed that brain SOD activity in D. melanogaster was
decreased by PQ in a dose-dependent manner and that
the decrease in SOD activity was strongly associated with
increased oxidative stress and neuronal DNA damage.
The catalytic actions of several enzymes including SOD
and monoamine oxidase (an enzyme involved in dopamine
metabolism) generate hydrogen peroxide (H2O2), a relatively
stable and diffusible ROS [53]. CAT and GPx are two major
antioxidant enzymes that work together to detoxify H2O2
to water and oxygen. In this study, although the differences
among the experimental groups were not significant, the
midbrain CAT activity was lower in group PQ andwas higher
in the two groups that received Tualang honey (groups TH
and PQ + TH) than in the control group (N). Increased CAT
activity following honey supplementation has previously
been reported in animal [54] and human disease models
[55, 56].
In comparison to the relatively unchanged midbrain
CAT activity observed, significant decreases in GPx activity
were observed in groups PQ and PQ + QH. The catalytic
activity of GPx requires coupled reactions with GSH redox
cycling during the decomposition of peroxides [57]. It has
been suggested that, at low concentrations of peroxides and
high GSH level, GPx decomposes H2O2 faster than CAT
[58]. Unlike GPx, CAT catalyzes the decomposition of H2O2
without requiring a hydrogen donor; therefore, it may play a
more important role during clearance of high concentrations
of H2O2, thus ensuring that the decomposition of peroxides
still occurs when GSH is depleted [58, 59]. In addition, GPx
and GSH are found mainly in the cytosol and mitochondria
and may therefore respond more quickly to extracellular
H2O2 in comparison to CAT, which is more restricted to
peroxisomes [60, 61]. Taken together, these phenomena may
explain the significant reduction in GPx but not CAT in the
present study, given that GPx may respond faster than CAT,
particularly during the early stages of the disease. A recent
study conducted byGobbo et al. [62] showed similar findings,
with activation of GPx occurring early during the response to
diabetes, whereas activation of CAT tended to occur at later
stages of untreated diabetes. Further research is needed to
understand the effects of PQ on GPx and CAT activities in
the midbrain.
GSH is themajor lowmolecular weight thiol inmammals
and is one of the most important antioxidants in the brain.
In addition to serving as a substrate for GPx activity, GSH
also plays important roles in cellular detoxification processes
through conjugation with various endogenous and xenobi-
otic compounds; these functions are mediated by GST [63].
In other words, GST play an important role in protecting cells
from injury by toxic chemicals and oxidative stress products.
Indeed, increased GST-pi isoenzyme expression following
systemic administration of MPTP was previously shown,
whereby GST-pi expression was suggested to be part of the
protective mechanism against MPTP-induced dopaminergic
neurodegeneration [64]. In this study, GST activity was
higher in group PQ than in the control group, although this
difference was not significant. Along with the slight decrease
in GSH observed in group PQ, this suggests that GST may
be involved in the detoxification of PQ via the conjugation of
PQ to GSH. GSH depletion without any significant changes
in GST activity has previously been reported in the SN
in Parkinson’s disease [65]. Higher GR activity, although
not statistically significant, was also observed in group PQ,
suggesting that the catalytic activity ofGR increased to restore
the marginally depleted GSH in group PQ.
Despite the significant decreases in GPx activity observed
in groups PQ and PQ + QH, a significant loss of TyrH-
positive neurons was only observed in group PQ. In addition,
group PQ showed the lowest GSH level among all of the
experimental groups, and treatment with honey or ubiquinol
ameliorated the decrease in the GSH level. Taken together,
these findings may explain the importance of GSH in pro-
tecting SNpc dopaminergic neurons [66] from PQ toxicity.
Decreased numbers of TyrH-positive neurons in the
SNpc have also previously been reported in an animal model
of PQ-induced neurotoxicity [16, 49, 67, 68]. It was suggested
that the compensatory mechanisms involving dopaminergic
and noradrenergic transmission as well as nondopaminergic
pathways were activated three days after PQ withdrawal [16].
For instance, when dopamine levels decrease due to the
loss of dopaminergic neurons, the surviving neurons may
rapidly upregulate TyrH to compensate for the loss [69]. The
activation of compensatory mechanisms may likely explain
the significant reduction in the number of TyrH-positive
neurons but not in the midbrain TyrH level in animals that
received PQ. In addition, because TyrH concentrations were
measured using the whole midbrain and were not restricted
to the SNpc as in the immunohistochemical analysis, these
changes may not represent the actual changes in the SNpc.
Due to marked respiratory distress observed in our
preliminary study (data not shown), the effects of four weekly
PQ injections on the lungs were also evaluated in this study.
Most of the published research has focused on the effects
of systemic administration of PQ on dopaminergic neurons
[16, 70, 71], and relatively few reports include the effects
of PQ on both dopaminergic neurons and on lung toxicity
[72–74]. In the present study, the four weekly intraperitoneal
injections of PQ caused significant decreases in the activity
levels of SOD and GST, along with a lower CAT activity and a
lower total GSHcontentwhen compared to the control group,
thus suggesting that PQ-induced ROS generation leads to
depletion of these antioxidant pools. However, pretreatment
with Tualang honey or ubiquinol ameliorates the toxic effects
of PQ, probably by restoring the depleted antioxidant pools.
However, no significant increase in lipid peroxidation was
observed via measuring MDA levels. In addition, clinical
observation of the rats during the experimental period did
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not reveal any signs of respiratory distress. A prolonged
observation periodmay be necessary to confirm the develop-
ment of respiratory failure, a frequent delayed fatal outcome
in subacute PQ toxicity, because significant changes in certain
oxidative markers were observed.
Tualang honey has previously been reported to be a good
source of phenolic compounds [46, 75] and to have strong
antioxidant properties [76, 77], suggesting that the protective
effects observed occur via antioxidant mechanisms, thus
conferring subsequent protection against oxidation-related
damage. For instance, pretreatment with kaempferol, one of
the flavonoids found in Tualang honey, has been reported
to increase the activities of SOD and GPx, reduce the MDA
content in the SN, and even prevent TyrH-positive neuronal
loss in anMPTP-inducedmousemodel of Parkinson’s disease
[78]. However, further investigations are needed to elucidate
the exact mechanism by which Tualang honey protects
against PQ-induced oxidative stress and related damage in
various cell types. A more prolonged experimental period
may be needed to elucidate the exact biochemical changes
involved, especially at the later stages of the disease. In
addition, the present study mainly focuses on the effects of
PQ in the region of the midbrain where the cell bodies of
the dopaminergic neurons reside. Measurement of striatal
dopamine concentrations and motor function assessment
may help to determine the functions of dopaminergic termi-
nals.
5. Conclusions
In conclusion, our current study model showed that four
weekly intraperitoneal injections of PQ elicited early oxida-
tive stress in both the midbrain and the lungs of exposed
rats. Pretreatment with Tualang honey or ubiquinol (positive
control) ameliorated the toxic effects of PQ observed in
both regions. Tualang honey has the potential to ameliorate
oxidative stress, as seen in the midbrain and lung of rats after
repeated exposure to PQ.
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